Cleared Traditional

K831063 - BUTTON INFUSER

K831063 is an FDA 510(k) clearance for BUTTON INFUSER, manufactured by Markwell Medical Institute, Inc.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 142-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1983
Decision
142d
Days
Class 2
Risk

K831063 is an FDA 510(k) clearance for the BUTTON INFUSER. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Markwell Medical Institute, Inc. (Mchenry, US). The FDA issued a Cleared decision on August 24, 1983 after a review of 142 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Markwell Medical Institute, Inc. devices

FDA 510(k) Submission Details - K831063

510(k) Number K831063 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 1983
Decision Date August 24, 1983
Days to Decision 142 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
13d slower than avg
Panel avg: 129d · This submission: 142d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 530
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K831063.
INTRADISCAL THERAPY TRAY
K834553 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Mar 1984
INTRADISCAL THERAPY TRAY
K832858 · Ulti-Med Intl., Inc. · Sep 1983
NEONATAL LUMBAR PUNCTURE TRAY
K832556 · American Pharmaseal Div. Ahsc · Sep 1983
AVL 0073 MICROSAMPLER
K831395 · Avl Scientific Corp. · Jul 1983
INTRADISCAL THERAPY NEEDLE
K831610 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jul 1983
INFANT CARE SYSTEM
K823899 · Narco Scientific · Apr 1983